About
About
Close
About Targovax
Management Team
Board of Directors
Careers
Technology
Technology
Close
ONCOS – Oncolyctic Virus
Intellectual Property Rights
Publications
Pipeline
Pipeline
Close
Our pipeline
Development Program
Melanoma
Mesothelioma
Next generation viruses
Partnering
Investors & Media
Investors & Media
Close
Our strategy
Press releases
Financial Reports
Presentations
Prospectus
Debt
Share information
Share facts
Largest shareholders
Dividend policy
Analyst coverage
Registrar and auditor
Events
Contact
Subscribe
Governance
Governance
Close
Corporate Governance Policy
Corporate Social Responsibility Principles
Remuneration Principles
About General Meeting
General Meetings
Board of Directors
Nomination Committee
Committees
Management
Articles of Association
Contacts
Contacts
Close
Offices
Investors & Media
About
About Targovax
Management Team
Board of Directors
Collaborations
Careers
Technology
ONCOS – Oncolyctic Virus
Intellectual Property Rights
Publications
Pipeline
Our pipeline
Development program
Partnering
TG Mutant RAS neoantigen vaccine – Available for partnering
Investors & Media
Our strategy
Share information
Share facts
Largest shareholders
Dividend policy
Analyst coverage
Registrar and auditor
Financial Reports
Press releases
Presentations
Prospectus
Debt
Events
Subscribe
Contact
Governance
Corporate Governance Report
Corporate Social Responsibility Principles
About General Meeting
General Meetings
Board of Directors
Nomination Committee
Committees
Management
Articles of Association
Contacts
Offices
Investors & Media
Search for:
Cookies
